AEE
71
-2
ISRG
56
2
EXC
69
-3
CVX
52
12
TSN
50
-2
OMC
51
-4
FIS
62
4
MRK
30
-3
GWW
41
-5
MCK
74
-4
AIG
71
-3
AFL
49
-3
SO
62
-4
PBI
50
4
ABBV
64
-4
SYF
55
7
EMN
46
-2
AMGN
25
-5
GE
61
6
INTC
29
6
AEE
71
-2
ISRG
56
2
EXC
69
-3
CVX
52
12
TSN
50
-2
OMC
51
-4
FIS
62
4
MRK
30
-3
GWW
41
-5
MCK
74
-4
AIG
71
-3
AFL
49
-3
SO
62
-4
PBI
50
4
ABBV
64
-4
SYF
55
7
EMN
46
-2
AMGN
25
-5
GE
61
6
INTC
29
6
Financhill
Back

Evans Bancorp Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
48

EVBN
Evans Bancorp

Last Price:
$38.75
Seasonality Move:
-1.23%
Buy
55

SRPT
Sarepta Therapeutics

Last Price:
$98.65
Seasonality Move:
6.73%
Sell
48
Evans Bancorp (EVBN) is a Sell

Is Evans Bancorp a Buy, Sell or Hold?

  • The current Evans Bancorp [EVBN] share price is $39.67. The Score for EVBN is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • EVBN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
55
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $99.77. The Score for SRPT is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

EVBN Stock Price Chart

What is Evans Bancorp's stock price today?

  • The Evans Bancorp share price today is $39.67
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EVBN is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $99.77
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

EVBN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.92 Sell
Relative Strength Index (14 RSI): 33.49 Sell
Chaikin Money Flow: 80574 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (41.22 - 44.26) Sell
Bollinger Bands (100): (41.01 - 44.57) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.4 Sell
Relative Strength Index (14 RSI): 37.2 Sell
Chaikin Money Flow: -420668 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (103.16 - 112.22) Sell
Bollinger Bands (100): (109.63 - 127.19) Sell

EVBN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 41.05 Sell
20-day SMA: 42.49 Sell
50-day SMA: 42.88 Sell
200-day SMA: 37.68 Buy
8-day EMA: 40.71 Sell
20-day EMA: 41.9 Sell
50-day EMA: 42.55 Sell
200-day EMA: 38.84 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 103.49 Sell
20-day SMA: 106.07 Sell
50-day SMA: 113.88 Sell
200-day SMA: 126.52 Sell
8-day EMA: 103.1 Sell
20-day EMA: 106.21 Sell
50-day EMA: 111.8 Sell
200-day EMA: 120.79 Sell

Evans Bancorp Earnings Growth & EVBN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.69 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.52 per share, an increase next quarter of $0.05 per share, an increase this year of $6.65 per share, and an increase next year of $5.25 per share.

Evans Bancorp Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):